Orthopaedic Spinal Research Laboratory and Scoliosis and Spine Center, St. Joseph Medical Center, Towson, Maryland 21204, USA.
J Neurosurg Spine. 2010 Aug;13(2):216-23. doi: 10.3171/2010.3.SPINE09512.
Using an in vivo caprine model, authors in this study compared the efficacy of autologous growth factors (AGFs) with autogenous graft for anterior cervical interbody arthrodesis.
Fourteen skeletally mature Nubian goats were used in this study and followed up for a period of 16 weeks postoperatively. Anterior cervical interbody arthrodesis was performed at the C3-4 and C5-6 vertebral levels. Four interbody treatment groups (7 animals in each group) were equally randomized among the 28 arthrodesis sites: Group 1, autograft alone; Group 2, autograft + cervical cage; Group 3, AGFs + cervical cage; and Group 4, autograft + anterior cervical plate. Groups 1 and 4 served as operative controls. Autologous growth factors were obtained preoperatively from venous blood and were ultra-concentrated. Following the 16-week survival period, interbody fusion success was evaluated based on radiographic, biomechanical, and histological analyses.
All goats survived surgery without incidence of vascular or infectious complications. Radiographic analysis by 3 independent observers indicated fusion rates ranging from 9 (43%) of 21 in the autograft-alone and autograft + cage groups to 12 (57%) of 21 in the autograft + anterior plate group. The sample size was not large enough to detect any statistical significance in these observed differences. Biomechanical testing revealed statistical differences (p < 0.05) between all treatments and the nonoperative controls under axial rotation and flexion and extension loading. Although the AGF + cage and autograft-alone treatments appeared to be statistically different from the intact spine during lateral bending, larger variances and smaller relative differences precluded a determination of statistical significance. Histomorphometric analysis of bone formation within the predefined fusion zone indicated quantities of bone within the interbody cage ranging from 21.3 +/- 14.7% for the AGF + cage group to 34.5 +/- 9.9% for the autograft-alone group.
The results indicated no differences in biomechanical findings among the treatment groups and comparable levels of trabecular bone formation within the fusion site between specimens treated with autogenous bone and those filled with the ultra-concentrated AGF extract. In addition, interbody cage treatments appeared to maintain disc space height better than autograft-alone treatments.
作者通过体内山羊模型比较了自体生长因子(AGF)与自体移植物在颈椎前路椎间融合中的疗效。
本研究使用了 14 只骨骼成熟的努比亚山羊,术后随访 16 周。在 C3-4 和 C5-6 椎体水平进行颈椎前路椎间融合。28 个融合部位随机分为 4 个椎间治疗组(每组 7 只动物):第 1 组为单纯自体骨移植;第 2 组为自体骨+颈椎 cage;第 3 组为 AGFs+颈椎 cage;第 4 组为自体骨+前路钢板。第 1 组和第 4 组为手术对照组。术前从静脉血中提取自体生长因子并进行超浓缩。16 周后,根据影像学、生物力学和组织学分析评估椎间融合成功率。
所有山羊均无血管或感染并发症存活。3 名独立观察者的影像学分析表明,单纯自体骨移植和自体骨+ cage 组的融合率为 21 例中的 9 例(43%),而自体骨+前路钢板组的融合率为 21 例中的 12 例(57%)。由于样本量太小,无法检测到这些观察到的差异有统计学意义。生物力学测试显示,在轴向旋转和屈伸加载下,所有治疗组与非手术对照组之间存在统计学差异(p<0.05)。虽然 AGF+cage 和单纯自体骨移植治疗组在侧屈时似乎与完整脊柱存在统计学差异,但较大的方差和较小的相对差异使统计学意义的确定变得不可能。在预定的融合区域内对骨形成进行组织形态计量学分析表明,AGF+cage 组的椎间 cage 内骨量为 21.3%±14.7%,而单纯自体骨移植组的骨量为 34.5%±9.9%。
结果表明,治疗组之间的生物力学结果没有差异,并且用自体骨和超浓缩 AGF 提取物填充的标本在融合部位的小梁骨形成水平相当。此外,与单纯自体骨移植治疗相比,椎间 cage 治疗似乎能更好地保持椎间盘高度。